These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 28525328)
21. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer. Ahn JY; Lee JS; Min HY; Lee HY Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450 [TBL] [Abstract][Full Text] [Related]
22. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA. Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Shin YK; Yoo BC; Hong YS; Chang HJ; Jung KH; Jeong SY; Park JG Electrophoresis; 2009 Jun; 30(12):2182-92. PubMed ID: 19582719 [TBL] [Abstract][Full Text] [Related]
24. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells. Saga Y; Suzuki M; Mizukami H; Kohno T; Takei Y; Fukushima M; Ozawa K Int J Cancer; 2003 Sep; 106(3):324-6. PubMed ID: 12845668 [TBL] [Abstract][Full Text] [Related]
26. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352 [TBL] [Abstract][Full Text] [Related]
27. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. Shimizu D; Ishikawa T; Ichikawa Y; Togo S; Hayasizaki Y; Okazaki Y; Danenberg PV; Shimada H Int J Oncol; 2005 Aug; 27(2):371-6. PubMed ID: 16010417 [TBL] [Abstract][Full Text] [Related]
28. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells. Emura T; Murakami Y; Nakagawa F; Fukushima M; Kitazato K Int J Mol Med; 2004 Apr; 13(4):545-9. PubMed ID: 15010854 [TBL] [Abstract][Full Text] [Related]
29. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells. Duz MB; Karatas OF Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138 [TBL] [Abstract][Full Text] [Related]
30. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis C Virus-Induced FUT8 Causes 5-FU Drug Resistance in Human Hepatoma Huh7.5.1 Cells. Li S; Liu XY; Pan Q; Wu J; Liu ZH; Wang Y; Liu M; Zhang XL Viruses; 2019 Apr; 11(4):. PubMed ID: 31022917 [TBL] [Abstract][Full Text] [Related]
32. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. Tsutani Y; Yoshida K; Sanada Y; Wada Y; Konishi K; Fukushima M; Okada M Oncol Rep; 2008 Dec; 20(6):1545-51. PubMed ID: 19020740 [TBL] [Abstract][Full Text] [Related]
33. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols. De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396 [TBL] [Abstract][Full Text] [Related]
34. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417 [TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932 [TBL] [Abstract][Full Text] [Related]
36. [Characterization of a fluorouracil-resistant human gastric carcinoma cell line and its morphological behavior]. Yue XF; Han JX; Dai ZQ; Liu MZ; Yang WY; Xu JY; Zhou JJ; Chen LJ; Zhang SY Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S1-4. PubMed ID: 8010063 [TBL] [Abstract][Full Text] [Related]
37. The role of dihydropyrimidine dehydrogenase expression in resistance to 5-fluorouracil in head and neck squamous cell carcinoma cells. Yasumatsu R; Nakashima T; Uryu H; Masuda M; Hirakawa N; Shiratsuchi H; Tomita K; Fukushima M; Komune S Oral Oncol; 2009 Feb; 45(2):141-7. PubMed ID: 18620897 [TBL] [Abstract][Full Text] [Related]
38. Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu. Zhang Y; Liu G; Lin C; Liao G; Tang B Life Sci; 2013 May; 92(17-19):896-902. PubMed ID: 23562851 [TBL] [Abstract][Full Text] [Related]
39. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A. Yan CM; Zhao YL; Cai HY; Miao GY; Ma W Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668 [TBL] [Abstract][Full Text] [Related]
40. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line. Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]